van de Linde Pieter, van der Boog Paul J M, Baranski Andrzej G, de Fijter Johan W, Ringers Jan, Schaapherder Alexander F M
Department of Transplantation Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Clin Transplant. 2006 Mar-Apr;20(2):253-7. doi: 10.1111/j.1399-0012.2005.00477.x.
Although there is a tendency to perform enteric drainage of pancreas transplants in simultaneous pancreas-kidney (SPK) transplantation, bladder drainage is still preferable in pancreas transplantation alone (PTA) or after a previous kidney transplantation (PAK). Our hypothesis was that enteric conversion of a bladder drained pancreas is an effective and safe procedure. We studied the complication rate and physiological effects of enteric conversion in patients with primary bladder-drained SPK transplantation.
We performed 51 enteric conversions in bladder-drained SPK transplant recipients. As we observed a low complication rate, with time enteric conversions were also performed for less strict and severe indications.
The main indications for conversion were urological problems, metabolic complications and reflux-pancreatitis. The median transplantation-conversion interval was 12 months (range 2-40 months). Post-operative complications consisted of seven urinary tract infections, two low-grade superficial wound infections, one minor bleeding, one phlebitis and one paralytic ileus. In two patients, a relaparotomy was necessary. No graft rejection following enteric conversion was found. Long-term renal and pancreatic function were not affected by the enteric conversion. Three-year patient, kidney and pancreas survival rates after enteric conversion were 93, 97 and 93%, respectively (censored data).
Enteric conversion after pancreas transplantation is an effective and safe procedure. Therefore, we suggest a policy of a two-step approach of primary bladder drainage followed by an enteric conversion of the pancreas in a selected group of SPK patients.
虽然在同期胰肾联合移植(SPK)中倾向于采用胰腺移植肠道引流术,但在单纯胰腺移植(PTA)或既往肾移植后(PAK)进行胰腺移植时,膀胱引流术仍是更可取的方法。我们的假设是,将膀胱引流的胰腺改为肠道引流是一种有效且安全的手术。我们研究了原发性膀胱引流的SPK移植患者肠道改道的并发症发生率和生理影响。
我们对51例膀胱引流的SPK移植受者进行了肠道改道手术。由于我们观察到并发症发生率较低,随着时间的推移,对于不太严格和严重的适应症也进行了肠道改道手术。
改道的主要适应症是泌尿系统问题、代谢并发症和反流性胰腺炎。移植至改道的中位间隔时间为12个月(范围2 - 40个月)。术后并发症包括7例尿路感染、2例轻度浅表伤口感染、1例轻微出血、1例静脉炎和1例麻痹性肠梗阻。有2例患者需要再次剖腹手术。肠道改道后未发现移植物排斥反应。肠道改道未影响长期肾脏和胰腺功能。肠道改道后3年的患者、肾脏和胰腺生存率分别为93%、97%和93%(删失数据)。
胰腺移植后肠道改道是一种有效且安全的手术。因此,我们建议对一组选定的SPK患者采取两步法策略,即首先进行原发性膀胱引流,然后对胰腺进行肠道改道。